Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice.
Norrie disease is an X-linked retinal dysplasia that presents with congenital blindness, sensorineural deafness, and mental retardation. Norrin, the protein product of the Norrie disease gene (NDP), is a secreted protein of unknown biochemical function. Norrie disease (Ndp(y/-)) mutant mice that are deficient in norrin develop blindness, show a distinct failure in retinal angiogenesis, and completely lack the deep capillary layers of the retina. We show here that the transgenic expression of ectopic norrin under control of a lens-specific promoter restores the formation of a normal retinal vascular network in Ndp(y/-) mutant mice. The improvement in structure correlates with restoration of neuronal function in the retina. In addition, lenses of transgenic mice with ectopic expression of norrin show significantly more capillaries in the hyaloid vasculature that surrounds the lens during development. In vitro, lenses of transgenic mice in coculture with microvascular endothelial cells induce proliferation of the cells. Transgenic mice with ectopic expression of norrin show more bromodeoxyuridine-labeled retinal progenitor cells at embryonic day 14.5 and thicker retinas at postnatal life than wild-type littermates, indicating a putative direct neurotrophic effect of norrin. These data provide direct evidence that norrin induces growth of ocular capillaries and that pharmacologic modulation of norrin might be used for treatment of the vascular abnormalities associated with Norrie disease or other vascular disorders of the retina.
Ohlmann
Andreas
A
Department of Anatomy, University of Erlangen-Nürnberg, D-91054 Erlangen, Germany.
Scholz
Michael
M
Goldwich
Andreas
A
Chauhan
Bharesh K
BK
Hudl
Kristiane
K
Ohlmann
Anne V
AV
Zrenner
Eberhart
E
Berger
Wolfgang
W
Cvekl
Ales
A
Seeliger
Mathias W
MW
Tamm
Ernst R
ER
D000818:Animals; D002196:Capillaries / Q000166:cytology / Q000254:growth & development; D002452:Cell Count; D002455:Cell Division; D002478:Cells, Cultured; D002645:Chickens; D018920:Coculture Techniques; D004596:Electroretinography; D042783:Endothelial Cells / Q000166:cytology; D004730:Endothelium, Vascular / Q000166:cytology; D005136:Eye Proteins / Q000235:genetics / Q000502:physiology*; D005786:Gene Expression Regulation; D006801:Humans; D007908:Lens, Crystalline / Q000166:cytology; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D018919:Neovascularization, Physiologic / Q000502:physiology*; D009419:Nerve Tissue Proteins / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology; D012160:Retina / Q000503:physiopathology / Q000648:ultrastructure; D012165:Retinal Ganglion Cells / Q000473:pathology; D012171:Retinal Vessels / Q000254:growth & development*; D012867:Skin / Q000098:blood supply; D038204:beta-Crystallins / Q000235:genetics
D005136:Eye Proteins; C489916:Ndph protein, mouse; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D011993:Recombinant Fusion Proteins; D038204:beta-Crystallins
Anat Embryol (Berl). 1999 Oct;200(4):403-11
10460477
Dev Biol. 2000 Jul 15;223(2):383-98
10882523
J Neurosci. 2000 Sep 15;20(18):6781-8
10995821
FASEB J. 2001 May;15(7):1215-7
11344092
J Neurosci. 2001 Jul 1;21(13):4761-71
11425903
Nat Genet. 2001 Sep;29(1):70-4
11528395
Prog Retin Eye Res. 2001 Nov;20(6):799-821
11587918
Invest Ophthalmol Vis Sci. 2002 Feb;43(2):522-7
11818400
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6222-7
11983912
J Neurosci. 2002 Jun 1;22(11):4286-92
12040033
Nat Genet. 2002 Oct;32(2):326-30
12172548
Prog Retin Eye Res. 2002 Sep;21(5):429-47
12207944
Dev Dyn. 2002 Oct;225(2):111-25
12242711
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):839-47
12556420
Brain Res Dev Brain Res. 2003 Feb 16;140(2):169-83
12586423
Am J Physiol Heart Circ Physiol. 2003 Nov;285(5):H1917-38
12842817
Nat Genet. 1992 Oct;2(2):139-43
1303264
Hum Mol Genet. 1992 Oct;1(7):461-5
1307245
Cell. 2004 Mar 19;116(6):883-95
15035989
Exp Eye Res. 2004 Apr;78(4):837-48
15037118
Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2384-90
15223821
J Histochem Cytochem. 1985 Jul;33(7):711-4
2409130
Anal Biochem. 1987 Nov 1;166(2):368-79
2449095
Microvasc Res. 1988 Nov;36(3):275-90
2466191
Invest Ophthalmol. 1972 Aug;11(8):691-8
5044721
J Comp Neurol. 1984 Nov 1;229(3):362-73
6501608
J Neurosci. 1995 Jul;15(7 Pt 1):4738-47
7623107
Biochim Biophys Acta. 1995 Mar 14;1261(1):68-76
7893762
Nat Genet. 1993 Dec;5(4):376-80
8298646
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):589-95
8570600
Hum Mol Genet. 1996 Jan;5(1):51-9
8789439
Mech Dev. 1996 Jun;57(1):79-89
8817455
Invest Ophthalmol Vis Sci. 1997 Mar;38(3):710-8
9071226
Science. 1997 Jul 11;277(5323):242-5
9211853
Am J Pathol. 1997 Jul;151(1):281-91
9212753
J Biol Chem. 1997 Dec 26;272(52):33410-5
9407136
Invest Ophthalmol Vis Sci. 1998 Jan;39(1):180-8
9430560
Invest Ophthalmol Vis Sci. 1998 Nov;39(12):2450-7
9804153
Acta Anat (Basel). 1998;162(2-3):95-100
9831755
FASEB J. 1999 Jan;13(1):9-22
9872925